Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single‑center retrospective study - Poll - MDSpire

Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single‑center retrospective study

  • By

  • Lulu Zhuang

  • Xiaoyan Yin

  • Xiaoli Liu

  • Defeng Liu

  • Zhonghui Wei

  • Yu Chen

  • Kaikai Zhao

  • Yankang Li

  • Jinming Yu

  • Xiangjiao Meng

  • February 4, 2025

  • 0 min

Share

Original Source(s)

Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single‑center retrospective study

  • by Lulu Zhuang, Xiaoyan Yin, Xiaoli Liu, Defeng Liu, Zhonghui Wei, Yu Chen, Kaikai Zhao, Yankang Li, Jinming Yu, Xiangjiao Meng

  • February 4, 2025

Related Content

Synchronous lung adenocarcinoma in situ and type B2-B3 thymoma in a frozen hemithorax: a case report and multidisciplinary approach

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research

Risk prediction models for venous thromboembolism in lung cancer patients after surgery: a systematic review and meta-analysis